| 1BSA |
|---|
| 2Glutamic dehydrogenase |
| 3B-Galactosidase |
| 4Ovalbumin |
Compound Name Bsa Kit |
CID 6913588 |
Molecular Formula C8H21NOSi2 |
Molecular Weight 203 |
No. Hydrogen Bond Acceptors 2 |
Applications
Proteins on Jupiter C4 300A
14761
Separation Mode: Reversed Phase
Reversed Phase
C4
HPLC
Pharmaceutical/Biopharmaceutical
Life Science
Protein
Biochemical Compound / Nutrient
Analytes
Details
LC Conditions (App ID: 14761)
Column: | ||||||||||||
Brand Name: | ||||||||||||
Part No: | ||||||||||||
Phase Name: C4 | ||||||||||||
Elution Type: Gradient | ||||||||||||
Mobile Phase: A: 0.1% TFA : H2O B: 0.08% TFA : ACN | ||||||||||||
Gradient Profile:
| ||||||||||||
Flow Rate: 1 mL/min | ||||||||||||
Temperature: 22°C | ||||||||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) (22°C) | ||||||||||||
Sample Note: SecurityGuard™ Guard Cartridge System extends column lifetime.
- SecurityGuard Cartridges, Widepore C4 4 x 3.0mm, 10/Pk Part No.: AJ0-4330
- Holder Part No.: KJ0-4282 |
Order Items Used in This Application
00F-4167-E0
Jupiter 5 µm C4 300 Å, LC Column 150 x 4.6 mm, Ea
Qty:
Similar Applications
search
BSA
Aeris 3.6 µm PEPTIDE XB-C18 100 Å, LC Column 250 x 4.6 mm, Ea
Reversed Phase
Aeris 3.6 µm PEPTIDE XB-C18 100 Å, LC Column 250 x 4.6 mm, Ea
Reversed Phase
Aeris 3.6 µm PEPTIDE XB-C18 100 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Aeris 3.6 µm PEPTIDE XB-C18 100 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Aeris 3.6 µm PEPTIDE XB-C18 100 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C18 200 Å, LC Column 250 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C18 200 Å, LC Column 250 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C18 200 Å, LC Column 150 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C18 200 Å, LC Column 150 x 2.1 mm, Ea
Reversed Phase
Aeris 3.6 µm WIDEPORE XB-C18 200 Å, LC Column 250 x 2.1 mm, Ea
Reversed Phase
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
